Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Enalare Therapeutics Inc.

Clinical trials sponsored by Enalare Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to stop Post-Surgery breathing danger Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New drug aims to stop Post-Surgery breathing danger

Prevention Not yet recruiting

This Phase 2 trial tests whether the drug ENA-001 can prevent respiratory depression (dangerously slow or shallow breathing) after major surgery under general anesthesia. About 200 adults having elective surgery will receive either ENA-001 or a placebo as an IV drip. The study is…

Phase 2 • Sponsor: Enalare Therapeutics Inc. • Aim: Prevention

Last updated Jun 27, 2026 09:09 UTC